Background
Christopher Adrian Rubalcaba was committed to the Colorado Mental Health Hospital in Pueblo in February 2026 after he was found incompetent to proceed in a criminal case. His treating psychiatrist, Dr. Martin Ahern, diagnosed him with schizophrenia marked by disorganized and tangential thinking and grandiose delusions. Rubalcaba had refused prescribed Zyprexa for several weeks.
The People sought authorization to administer antipsychotic medications involuntarily. At the evidentiary hearing, Dr. Ahern recommended Saphris, Risperdal, and Clozaril and testified that untreated psychosis would likely cause cognitive decline and could make Rubalcaba’s condition treatment-resistant. Rubalcaba denied having a mental illness and objected based on concerns about prior gastrointestinal bleeding, shaking, nausea, and possible ulcers.
The Court’s Holding
The Colorado Court of Appeals affirmed the order authorizing involuntary medication. It held that the district court was not required to make detailed written findings because it made detailed, individualized oral findings on each applicable element of People v. Medina, and those findings were preserved in the hearing transcript.
The record supported the district court’s conclusions that Rubalcaba could not effectively participate in treatment decisions, that medication was necessary to prevent significant and likely long-term deterioration, and that his treatment need outweighed his legitimate concerns about side effects. The trial court permissibly credited Dr. Ahern’s testimony that Rubalcaba’s proposed medications would be monitored and that the harms of remaining unmedicated exceeded their risks.
Key Takeaways
- Detailed oral findings can satisfy Medina; the law does not require detailed written findings.
- A treating physician’s testimony may support an involuntary-medication order.
- Courts may credit evidence that untreated psychosis will cause cognitive decline or future treatment resistance.
Why It Matters
The decision confirms that appellate review of involuntary-medication orders focuses on the full record, including the trial court’s oral ruling, rather than the form of a written order alone. It also illustrates the deference given to trial-court credibility determinations where psychiatric testimony addresses both medication risks and the consequences of non-treatment.